1,789 reports of this reaction
3.4% of all SORAFENIB reports
#4 most reported adverse reaction
FATIGUE is the #4 most commonly reported adverse reaction for SORAFENIB, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 1,789 FDA adverse event reports linking SORAFENIB to FATIGUE. This represents approximately 3.4% of all 51,866 adverse event reports for this drug.
Patients taking SORAFENIB who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among SORAFENIB users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for SORAFENIB:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,789 FDA reports for SORAFENIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.4% of all adverse event reports for SORAFENIB, making it a notable side effect.
If you experience fatigue while taking SORAFENIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.